|
Re: Election Day
|
5
|
Resverlogix Corp.
|
Nov 05, 2020 10:09PM
|
|
Re: AACR 2018
|
5
|
Zenith Epigenetics
|
Feb 21, 2018 11:38AM
|
|
Re: My guess is a second BTD is coming
|
5
|
Resverlogix Corp.
|
Feb 08, 2020 01:56PM
|
|
Re: More news on the way? They say things happen in 3s.....
|
5
|
Resverlogix Corp.
|
May 24, 2017 10:31AM
|
|
Re: What now
|
5
|
Zenith Epigenetics
|
Jun 12, 2017 08:06PM
|
|
Re: Zenith Epigenetics Announces Publication of Covalent Bromodomain Inhibitors, Offering a Novel Approach to Targeting BET Bromodomains
|
5
|
Zenith Epigenetics
|
Oct 01, 2018 09:57AM
|
|
Zacks SCR Report 6/14/17
|
5
|
Resverlogix Corp.
|
Jun 15, 2017 04:38PM
|
|
Re: The glucose effect?
|
5
|
Resverlogix Corp.
|
Feb 21, 2019 04:56PM
|
|
Top-line vs. Full Detailed Clinical Trial Results
|
5
|
Resverlogix Corp.
|
Aug 28, 2018 03:08PM
|
|
Re: BETonMACE Enrollment
|
5
|
Resverlogix Corp.
|
Feb 23, 2019 02:33PM
|
|
HDL from an Alzheimer's disease perspective
|
5
|
Resverlogix Corp.
|
Jun 27, 2019 08:41AM
|
|
Re: We might already be at 125 events....
|
5
|
Resverlogix Corp.
|
Oct 26, 2017 01:15PM
|
|
Re: Biotech’s – Full Disclosure can take weeks if not months
|
5
|
Resverlogix Corp.
|
Nov 13, 2019 12:03PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
5
|
Zenith Epigenetics
|
Jul 16, 2017 11:12PM
|
|
Re: No ESC 2019 Late Breaker
|
5
|
Resverlogix Corp.
|
Jul 01, 2019 08:38PM
|
|
Re: A week
|
5
|
Resverlogix Corp.
|
Nov 28, 2019 06:45PM
|
|
Re: Looks like Top SoC for Diabetes is evolving yet again:
|
5
|
Resverlogix Corp.
|
Jan 17, 2020 04:14PM
|
|
Re: Article on NASH Liver Disease
|
5
|
Resverlogix Corp.
|
Aug 18, 2019 09:58AM
|
|
Zenith AGM thoughts
|
5
|
Zenith Epigenetics
|
Nov 28, 2017 03:59PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
5
|
Resverlogix Corp.
|
Mar 30, 2020 09:25AM
|
